CCR4-351

N/A

Report date: 2023/04/13 10:01:31
NME

Base Information

Drug NameCCR4-351
Drug Alias NameCCR-4351CCR4-IN-31CCR4-351
ClassificationSmall molecules
Mechanisms of ActionC-C chemokine receptor type 4 antagonists
TargetsC-C chemokine receptor type 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRapt Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRapt Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A